Analysis of the clinical characteristics and misdiagnosis of area postrema syndrome manifesting as intractable nausea, vomiting, and hiccups in neuromyelitis optica spectrum disorders.
10.3760/cma.j.cn112138-20220621-00468
- Author:
Shi Min ZHANG
1
;
Feng QIU
2
;
Xuan SUN
3
;
Hui SUN
1
;
Lei WU
1
;
De Hui HUANG
1
;
Wei Ping WU
1
Author Information
1. Department of Neurology, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
2. Department of Neurology, the Eighth Medical Center,Chinese PLA General Hospital,Beijing 100091, China.
3. Department of Geriatric Neurology, the Second Medical Center,Chinese PLA General Hospital, Beijing 100853, China.
- Publication Type:Journal Article
- MeSH:
Male;
Female;
Humans;
Child, Preschool;
Child;
Adolescent;
Young Adult;
Adult;
Middle Aged;
Aged;
Neuromyelitis Optica/diagnosis*;
Area Postrema;
Retrospective Studies;
Hiccup/complications*;
Vomiting/etiology*;
Nausea/etiology*;
Inflammation;
Syndrome;
Autoantibodies;
Diagnostic Errors;
Aquaporin 4
- From:
Chinese Journal of Internal Medicine
2023;62(6):705-710
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the misdiagnosis of area postrema syndrome (APS) manifesting as intractable nausea, vomiting and hiccups in neuromyelitis optic spectrum disease (NMOSD) and reduce the risk of misdiagnosis. Methods: We retrospectively analyzed data from NMOSD patients attending the Department of Neurology at the First Medical Center of PLA General Hospital between January 2019 and July 2021. SPSS25.0 was then used to analyze the manifestations, misdiagnosis, and mistreatment of APS. Results: A total of 207 patients with NMOSD were included, including 21 males and 186 females. The mean age of onset was 39±15 years (range: 5-72 years). The proportion of patients who were positive for serum aquaporin 4 antibody was 82.6% (171/207). In total, 35.7% (74/207) of the NMOSD patients experienced APS during the disease course; of these patients, 70.3% (52/74) had APS as the first symptom and 29.7% (22/74) had APS as a secondary symptom. The misdiagnosis rates for these conditions were 90.4% (47/52) and 50.0% (11/22), respectively. As the first symptom, 19.2% (10/52) of patients during APS presented only with intractable nausea, vomiting and hiccups; 80.8% (42/52) of patients experienced other neurological symptoms. The Departments of Gastroenterology and General Medicine were the departments that most frequently made the first diagnosis of APS, accounting for 54.1% and 17.6% of patients, respectively. The most common misdiagnoses related to diseases of the digestive system and the median duration of misdiagnosis was 37 days. Conclusions: APS is a common symptom of NMOSD and is associated with a high rate of misdiagnosis. Other concomitant symptoms often occur with APS. Gaining an increased awareness of this disease/syndrome, obtaining a detailed patient history, and performing physical examinations are essential if we are to reduce and avoid misdiagnosis.
